PharmacoMRI and cognitive effects of the low-trapping NMDA channel blocker AZD6765 compared with ketamine in untreated major depressive disorder. 28th CINP World Congress of Neuropsychopharmacology in Stockholm, Sweden. 2012

JF William Deakin, Steve Williams, Darragh Downey, Shane McKie, Guy M Goodwin, Angela Rylands, Catherine J Harmer, Kevin J Craig, Colin T Dourish, Gerard R Dawson, Dennis J McCarthy, Mark A Smith (2012).